Neurogene, Inc. (NGNE)
21.19
-0.07
(-0.33%)
USD |
NASDAQ |
Dec 12, 14:47
Neurogene EPS Diluted (Quarterly): -0.9898 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Verastem, Inc. | -1.347 |
| Anavex Life Sciences Corp. | -0.1144 |
| Coherus Oncology, Inc. | -0.3021 |
| Ocugen, Inc. | -0.066 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.95M |
| Total Expenses (Quarterly) | 20.95M |
| Enterprise Value | 74.11M |
| Earnings Yield | -20.90% |
| Normalized Earnings Yield | -20.90 |